CCR2 and neoplasm: However, Craddock et al. suggest that the targeting of non-malignant tissue expressing CCL2 by CCR2b-transduced CAR T cells may not be an issue given the high level of CCL2 produced by tumours as compared to that of normal tissue [40], although this has yet to be experimentally evaluated.